Membrane apheresis technology: Historical perspective and new trends toward bioincompatible systems

Therapeutic Apheresis

Volumn 1, Issue 1, 1997, Pages 5-12

  Nosé, Yukihiko ^a   Yamaji, Ken ^a   Sueoka, Akinori ^a   Yamane, Shingo ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Biocompatibility; Bioincompatible apheresis system; Procedurally induced immunomodulation

Indexed keywords

BIOMATERIAL;

ANTIBODY PRODUCTION; APHERESIS; ARTIFICIAL MEMBRANE; BLOOD; EDITORIAL; HUMAN; IMMUNOLOGY; INSTRUMENTATION; TIME;

ANTIBODY FORMATION; BIOCOMPATIBLE MATERIALS; BLOOD; BLOOD COMPONENT REMOVAL; HUMANS; MEMBRANES, ARTIFICIAL; TIME FACTORS;

EID: 0031061198     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00005.x     Document Type: Article

References (11)

1. Mito M, Nishimura A, Sumiyoshi A, Kawai M, Nosé Y, Kawamura T, Yoshimoto A. On extracorporeal circulation of membrane artificial organs (liver and kidney). Sogo Igaku 1960;17:86.
2. Craddock PR, Fehr J, Brigham KL, Kronenberg PS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769-74.
3. Haeffne-Cavaillon N, Kazatchkine MD. Methods for assessing monocytic cytokine production as an index of biocompatibility. Nephrol Dial Transplant 1994;9:112-5.
4. Murabayashi S, Nosé Y. Biocompatibility: Bioengineering aspects. Artif Organs 1986;10:114-21.
5. Omokawa S, Malchesky PS, Yamashita M, Goldcamp JB, Nosé Y. Anticoagulant and membrane effects on humoral and cellular changes during plasmapheresis. Trans ASAIO 1988; 34:404-9.
6. Lambrecht LK, Young BR, Stafford RE, Park K, Albrecht RM, Mosher DF, Cooper SL. The influence of preadsorbed canine von Willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induces thrombosis. Trombosis Res 1986;41:99-117.
7. Kempczinski RF, Ramalanjaona GR, Douville C, Silberstein EB. Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft. Surgery 1987;101:439-44.
8. Naito H. Non-anticoagulant hemodialysis. Nippon Rinsyo 1985;43:182-187.
9. Omokawa S, Suzuki T, Murabayashi S, Malchesky PS, Nosé Y. Procedurally induced immunomodulation in membrane plasmapheresis. In: Oda T, eds. Therapeutic plasmapheresis (VII). Cleveland: ISAO Press, 1987:3-21.
10. Nosé Y. Bioincompatible biomaterials for extracorporeal immunomodulation. Artif Organs 1988;12;377-8.
11. Nosé Y. Current status and future trends for therapeutic plasmapheresis: Towards cellular modulation. In: Koga, N, Inoue N, Nakagawa S, eds. Therapeutic plasmapheresis (IX). Cleveland: ICAOT Press, 1991:3-15.